Wang Z, Qiu J, Shen X, Yang F, Liu X, Wang X
Abdom Radiol (NY). 2025; .
PMID: 39841226
DOI: 10.1007/s00261-024-04759-x.
Bourdeleau P, Couvelard A, Ronot M, Lebtahi R, Hentic O, Ruszniewski P
Ther Adv Med Oncol. 2023; 15:17588359231179310.
PMID: 37323185
PMC: 10262621.
DOI: 10.1177/17588359231179310.
Reccia I, Pai M, Kumar J, Spalding D, Frilling A
Cancers (Basel). 2023; 15(6).
PMID: 36980746
PMC: 10047148.
DOI: 10.3390/cancers15061861.
Yang D, Cheng J, Tian X, Zhang Q, Yu L, Qiu Y
Diagnostics (Basel). 2023; 13(2).
PMID: 36673048
PMC: 9858178.
DOI: 10.3390/diagnostics13020238.
Javed A, Pulvirenti A, Razi S, Zheng J, Michelakos T, Sekigami Y
Ann Surg. 2022; 277(6):e1284-e1290.
PMID: 35081574
PMC: 9364076.
DOI: 10.1097/SLA.0000000000005390.
Neuroendocrine pancreatic tumor in a patient with dual diagnosis of tuberous sclerosis complex and basement membrane disease: A case report and review of the literature.
Kopadze S, Shoshiashvili I, Dumbadze A, Tkemaladze T, Kiladze I
Radiol Case Rep. 2021; 16(11):3581-3588.
PMID: 34584596
PMC: 8453210.
DOI: 10.1016/j.radcr.2021.08.041.
Quantitative Computed Tomography Image Analysis to Predict Pancreatic Neuroendocrine Tumor Grade.
Pulvirenti A, Yamashita R, Chakraborty J, Horvat N, Seier K, McIntyre C
JCO Clin Cancer Inform. 2021; 5:679-694.
PMID: 34138636
PMC: 8462651.
DOI: 10.1200/CCI.20.00121.
Increased neutrophil-lymphocyte ratio predicts recurrence in patients with well-differentiated pancreatic neuroendocrine neoplasm based on the 2017 World Health Organization classification.
Miura T, Ohtsuka H, Aoki T, Aoki S, Hata T, Takadate T
BMC Surg. 2021; 21(1):176.
PMID: 33789657
PMC: 8011407.
DOI: 10.1186/s12893-021-01178-3.
Role of Endoscopic Ultrasound in the Diagnosis of Pancreatic Neuroendocrine Neoplasms.
Ishii T, Katanuma A, Toyonaga H, Chikugo K, Nasuno H, Kin T
Diagnostics (Basel). 2021; 11(2).
PMID: 33672085
PMC: 7919683.
DOI: 10.3390/diagnostics11020316.
CT-derived radiomic features to discriminate histologic characteristics of pancreatic neuroendocrine tumors.
Benedetti G, Mori M, Panzeri M, Barbera M, Palumbo D, Sini C
Radiol Med. 2021; 126(6):745-760.
PMID: 33523367
DOI: 10.1007/s11547-021-01333-z.
Grading of pancreatic neuroendocrine tumors on endoscopic ultrasound-guided fine-needle aspiration using Ki-67 index and 2017 World Health Organization criteria: An analysis of 32 cases.
Kalantri S, Bakshi P, Verma K
Cytojournal. 2020; 17:21.
PMID: 33093857
PMC: 7568229.
DOI: 10.25259/Cytojournal_4_2020.
Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT.
Majala S, Seppanen H, Kemppainen J, Sundstrom J, Schalin-Jantti C, Gullichsen R
EJNMMI Res. 2019; 9(1):116.
PMID: 31872324
PMC: 6928175.
DOI: 10.1186/s13550-019-0585-7.
Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration.
Hackeng W, Morsink F, Moons L, Heaphy C, Offerhaus G, Dreijerink K
Diagn Cytopathol. 2019; 48(4):308-315.
PMID: 31846235
PMC: 7079001.
DOI: 10.1002/dc.24368.
Interesting pancreatic tumour in the background of Tuberous Sclerosis.
Amarjothi J, Jesudason J, Ramasamy V, Babu O
BMJ Case Rep. 2019; 12(8).
PMID: 31383671
PMC: 6685411.
DOI: 10.1136/bcr-2018-227292.
The Role of Endoscopic Ultrasound-Guided Ki67 in the Management of Non-Functioning Pancreatic Neuroendocrine Tumors.
Cui Y, Khanna L, Saqi A, Crapanzano J, Mitchell J, Sethi A
Clin Endosc. 2019; 53(2):213-220.
PMID: 31302988
PMC: 7137561.
DOI: 10.5946/ce.2019.068.
Fine-Needle Aspiration-Based Grading of Pancreatic Neuroendocrine Neoplasms Using Ki-67: Is Accurate WHO Grading Possible on Cytologic Material?.
Weiss V, Kiernan C, Wright J, Merchant N, Coogan A, Shi C
J Am Soc Cytopathol. 2018; 7(3):154-459.
PMID: 30038894
PMC: 6054317.
DOI: 10.1016/j.jasc.2018.02.001.
Assessment of pancreatic neuroendocrine tumor cytologic genotype diversity to guide personalized medicine using a custom gastroenteropancreatic next-generation sequencing panel.
Gleeson F, Voss J, Kipp B, Kerr S, Van Arnam J, Mills J
Oncotarget. 2017; 8(55):93464-93475.
PMID: 29212165
PMC: 5706811.
DOI: 10.18632/oncotarget.18750.
Early Gastroenteropancreatic Neuroendocrine Tumors: Endoscopic Therapy and Surveillance.
Scherubl H, Cadiot G
Visc Med. 2017; 33(5):332-338.
PMID: 29177161
PMC: 5697500.
DOI: 10.1159/000459404.
KI-67 heterogeneity in well differentiated gastro-entero-pancreatic neuroendocrine tumors: when is biopsy reliable for grade assessment?.
Grillo F, Valle L, Ferone D, Albertelli M, Brisigotti M, Cittadini G
Endocrine. 2017; 57(3):494-502.
PMID: 28726181
DOI: 10.1007/s12020-017-1364-8.
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage.
De Robertis R, Cingarlini S, Martini P, Ortolani S, Butturini G, Landoni L
World J Gastroenterol. 2017; 23(2):275-285.
PMID: 28127201
PMC: 5236507.
DOI: 10.3748/wjg.v23.i2.275.